What Is “Data-Driven” Approval Routing?
The idea the whole platform rests on: approvals routed by the data on the transaction, not by a static org chart. Start here if…
- iApprove™
Short product demos of ISS Group workflows executing inside QAD — approval routing, requisitions, budgets, supplier invoices and mobile approvals.
The idea the whole platform rests on: approvals routed by the data on the transaction, not by a static org chart. Start here if…
How iApprove™ routes a request for approval on your own data — amount, GL account, cost center, supplier — and writes the result straight…
A purchase requisition from entry to approved PO in QAD, routed against your own purchasing policy rather than an inbox.
Checking a requisition against the budget before it is approved, so overspend is prevented at the point of request instead of found at month…
Approving from a phone with the same rules, the same audit trail and the same QAD update as the desktop.
Buying from a supplier’s own catalogue without leaving the requisition, and returning a priced line QAD can act on.
Matching a supplier invoice against the PO and the receipt, routing the exceptions, and vouchering the rest in QAD without re-keying.
MAI’s own account of putting data-driven approval routing into their QAD environment, presented at the QAD Fall 2020 User Group Conference.
Watch the video →SI-Bone on automating QAD-integrated approvals in a regulated medical-device environment, from the QAD Spring 2021 User Group Conference.
Watch the video →See how ISS Group workflows would operate inside your QAD environment — tailored to your processes, your data and your controls.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.